Skip to main content

Table 4 Changes in liver steatosis

From: The effect of DASH diet on glycemic response, meta-inflammation and serum LPS in obese patients with NAFLD: a double-blind controlled randomized clinical trial

Variable

DASH

(N = 20)

Control

(N = 20)

P*

NAFLD severity

Baseline

  

0.273

Grade I

10(50.0)

8 (40.0)

 

Grade II

10 (50.0)

12 (60.0)

 

End

Grade 0

12 (60.0)

4(20.0)

0.012

Grade I

8 (40.0)

12 (60.0)

 

Grade II

0 (0.0)

4 (20.0)

 

Liver steatosis severity

No change

1 (5.0)

12 (60.0)

 

1 grade reduction

16 (80.0)

8(40.0)

 

2 grade reduction

3 (15.0)

0 (0.0)

 

ARR

1 grade reduction (%)

40

 

2 grade reduction (%)

15

 

NNT

1 grade reduction

2.5

 

2 grade reduction

6.67

 
  1. Bold indicate p < 0.05 is statistically significant
  2. *Chi square test
  3. DASH, Dietary Approaches to Stop Hypertension; Non-alcoholic fatty liver disease; ARR, Attributable risk reduction; NNT, Number needed to treat